ArticleParasites & vectors2026
In vivo evaluation of a cytochrome P450 gene from poultry red mite, Dermanyssus gallinae, as a vaccine antigen for chicks.
Article in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundDermanyssus gallinae is a prevalent ectoparasite in the poultry farms, inflicting damage on chicken health through blood-sucking. Chemical acaricides commonly used for mite control often show reduced efficacy due to the development of resistance. Therefore, alternative control methods are needed, and vaccination is a promising strategy for controlling D. gallinae.
methodsThe mRNA expression of Deg-CYP-3 in mites at various developmental stages, as well as under fed and starved conditions, was analyzed. Subsequently, recombinant protein rCYP-3 was induced, purified, and employed for immunization. Following immunization, antibodies were analyzed and mite challenge was then conducted. Following a 12 h period of blood-feeding on chicks, the mites were collected to evaluate the acaricidal efficacy of the rCYP-3 vaccine.
resultsThe Deg-CYP-3 gene was expressed across all life stages and maintained stable expression levels under both fed and starved conditions. The recombinant protein rCYP-3 was successfully expressed in Escherichia coli and efficiently secreted into the culture supernatant. Immunization with rCYP-3 induced a specific IgY immune response in chicks, as confirmed by ELISA. Moreover, anti-rCYP-3 serum specifically recognized P450 proteins extracted from D. gallinae, as demonstrated by Western blot analysis. Immunization resulted in an 8.1% reduction in adult mite survival (P > 0.05), whereas nymph survival decreased significantly by 22.4% (P < 0.01). In addition, oviposition rate, hatching rate, and fecundity were reduced by 2.8%, 2.2%, and 22.0%, respectively, in the immunized group. Overall, vaccine efficacy was calculated to be 30.6% in immunized birds. Furthermore, the expression level of Deg-CYP-3 in mites fed on immunized hosts was significantly lower than that in mites from the unimmunized control group.
conclusionsOur findings demonstrated that the Deg-CYP-3 gene exhibits high transcriptional activity during both the adult and nymph stages of D. gallinae. Moreover, its expression remains consistent regardless of the feeding status of adult mites. Immunization with rCYP-3 effectively reduced mite survival, reproductive capacity, and gene expression levels, demonstrating its potential as a preventive and control strategy against D. gallinae.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.